RECURRENT NON-SMALL CELL LUNG CARCINOMA

This study tested a combination of two drugs—TG4010 (a vaccine that helps the immune system attack cancer) and nivolumab (an immunotherapy that removes cancer's brakes on immune cells)—in 13 people with advanced non-small cell lung cancer who had already tried other treatments. T…

This study looked at whether adding metformin (a common diabetes medicine) to standard chemotherapy and radiation therapy helps people with stage III non-small cell lung cancer live longer without the cancer growing. About 170 people took part. The goal was to see if the combinat…

This study tested a combination of two drugs—sEphB4-HSA and pembrolizumab—in 42 people with advanced non-small cell lung cancer or head & neck cancer that had spread or come back. The goal was to see if the combo could shrink tumors better than standard treatments. Participants h…

This study tested a combination of two drugs, auranofin and sirolimus, in 29 people with advanced or recurrent lung cancer who had run out of standard treatment options. The goal was to find the best dose and see if the combo could slow cancer growth. The trial focused on safety …

This early-stage study tested a precise, high-dose radiation technique called SBRT in 42 adults with breast, lung, or prostate cancer that had spread to several places in the body. The main goal was to find the safest dose and check for side effects. Researchers hope this approac…